|
1 Duenas GA, Getina PL, Onate LF, et al. Multimodal treatment of locally advanced cervical cancer. Arch Med Res，2005, 36(2)：129－135.
|
|
2 Wang H, Tang LY, Zhang XH. Clinical research on preoperative interventional chemotherapy for uterine cervical cancer. J Chongqing Med Univ, 2007, 32(2)：182－185.[王辉，唐良萏，张新华. 宫颈癌术前介入化疗的临床研究. 重庆医科大学学报，2007, 32(2): 182－185.]
|
|
3 Pignata S, Silvestro G, Ferrari E, et al. PhaseⅡ study of cisplatin and vinorelbine as first－line chemotherapy in patients with carcinoma of the uterine cervix. J Clin Oncol, 1999, 17(3): 756－758.
|
|
4 Motoyama S, Hamana S, Ku Y, et al. Neoadjuvant high－dose intraarterial infusion chemotherapy under percutaneous pelvic perfusion with extracorporeal chemofiltration in patients with stages Ⅲa－Ⅳa cervical cancer. Gynecol Oncol, 2004, 95(3)：576－582.
|
|
5 Rew DA, Wilson GD. Cell production rates in human tissues and tumors and their significance.Part Ⅱ：Clinical data. Eur J Surg Oncol, 2000, 26(4): 405－417.
|
|
6 Benedetti－Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: Results from the Itaian multicenter randomized study. J Clin Oncol, 2002, 20(1): 179－188.
|
|
7 Scheungraber C, Muller B, Kohler C, et al. Dection of dissmernated tumor cells in patients with cervical cancer. J Cancer Res Clin Oncol, 2002, 128(6)：329－335.
|
|
8 Kobayashi K, Furukawa A, Takahashi M, et al. Neoadjuvant intra－arterial chemotherapy for locally advanced uterine cervical cancer, clinical efficacy and factors influencing response. Cardiovasc Intervene Radiol, 2003, 26(3)：234－241.
|
|
9 Yamakawa Y, Fujimura M, Hidaka T, et al. Neoadjuvant intraarterial infusion chemotherapy in patients with stage Ⅰb2－Ⅲb cervical cancer. J Gynecol Oncol, 2000, 77(2): 264－270.
|
|
10 Rose PG. Chemoradiotherapy for cervical cancer. Eur J Cancer, 2002, 38(2): 270－278.
|
|
11 Aoki Y, Sato T, Watanabe M, et al. Neoadjuvant chemotherapy using low－dose consecutive intra－arterial infusion of cisplatin combined with 5－fluorouracil for locally advanced cervical adenocarcinoma. J Gynecol Oncol, 2001, 88: 496－499.
|
|
12 Strecker EP, Heber R, Boos I, et al. Preliminary experience with loco regional inter－arterial chemotherapy of uterine cervical or endometrial cancer using the peripheral implantable port system (PIPS): A feasibility study. Cardiovasc Intervene Radiol, 2003, 26(2)：118－120.
|
|
13 Wang P, Peng ZL, Zhang JW, et al. Comparison of therapeutical effect between arterial interventional chemotherapy and venous chemotherapy on bulky or loally cervical cancer. Clin J Obstet Gynecol, 2005, 40(4): 227－230.[王平，彭芝兰，张家文等. 子宫颈癌新辅助化疗中不同化疗途径的疗效比较. 中华妇科杂志，2005, 40(4)：227－230.]
|
|
14 Vishnevskaia EE. Long－term results of comprehensive treatment for cervical cancer with poor prognosis. Vopr Onkol, 1999, 45(4): 420－423.
|
|
15 Nagata Y. Clinical results of transcatheter arterial infusion for utrine cervical cancer. Am J Clin Oncol, 1999, 22(1): 97－102.
|